Gyre Therapeutics GAAP EPS of $0.03 in-line, revenue of $30.56M misses by $2.37M
Source: SeekingAlpha
2025-11-07 14:15:02 ET
More on Gyre Therapeutics
- Gyre Therapeutics, Inc. (GYRE) Presents at H.C. Wainwright 27th Annual Global Investment Conference - Slideshow
- Seeking Alpha’s Quant Rating on Gyre Therapeutics
- Historical earnings data for Gyre Therapeutics
- Financial information for Gyre Therapeutics
Read the full article on Seeking Alpha
For further details see:
Gyre Therapeutics GAAP EPS of $0.03 in-line, revenue of $30.56M misses by $2.37M
Gyre Therapeutics Inc.
NASDAQ: GYRE
GYRE Trading
-4.69% G/L:
$7.615 Last:
87,188 Volume:
$7.98 Open:
GYRE Latest News
GYRE Stock Data
$767,775,261
71,190,203
0.16%
17
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
